VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1606540
Sex: F
Age: 39
State: MI

Vax Date: 03/03/2021
Onset Date: 04/05/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Nerve pain; really bad dizziness; severe pain like burning in arms and legs; Muscle spasm; Burning arms and legs; a pretty bad rash on her chest and neck; This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (really bad dizziness), PAIN (severe pain like burning in arms and legs), BURNING SENSATION (Burning arms and legs), MUSCLE SPASMS (Muscle spasm) and NEURALGIA (Nerve pain) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Hypothyroidism since 07-Jan-2010 and Drug allergy (Phenergan). Concomitant products included CELECOXIB (CELEXA [CELECOXIB]) for Anxiety, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism, CALCIUM, MULTIVITAMIN [VITAMINS NOS] and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced BURNING SENSATION (Burning arms and legs) and RASH (a pretty bad rash on her chest and neck). On 08-Apr-2021, the patient experienced DIZZINESS (really bad dizziness), PAIN (severe pain like burning in arms and legs) and MUSCLE SPASMS (Muscle spasm). On an unknown date, the patient experienced NEURALGIA (Nerve pain). The patient was treated with CORTISONE at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency; GABAPENTIN (NEURONTIN) for Adverse event, at an unspecified dose and frequency and TIZANIDINE HYDROCHLORIDE (ZANAFLEX) for Adverse event, at an unspecified dose and frequency. On 19-Apr-2021, DIZZINESS (really bad dizziness) and RASH (a pretty bad rash on her chest and neck) had resolved. At the time of the report, PAIN (severe pain like burning in arms and legs), BURNING SENSATION (Burning arms and legs), MUSCLE SPASMS (Muscle spasm) and NEURALGIA (Nerve pain) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. It was reported the patient visited the ER on 05-Apr-2021 and visited a doctor's office/urgent care on 08-Apr-2021 This case was linked to MOD-2021-073955 (E2B Linked Report). This case was linked to MOD-2021-073955 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Updated patient demographics, current conditions and concomitant medications.Updated event outcome from unknown to recovered for following events: Rash and dizziness. On 19-Jul-2021: Follow up contains no new information. On 19-Jul-2021: Event outcome updated for muscle spasm, burning, rash and dizziness updated. New event nerve pain added, treatment medications added. Sought medical care.; Sender's Comments: MOD-2021-073955:

Other Meds: CELEXA [CELECOXIB]; SYNTHROID; CALCIUM; MULTIVITAMIN [VITAMINS NOS]; VITAMIN D 2000

Current Illness: Drug allergy (Phenergan); Hypothyroidism

ID: 1606541
Sex: M
Age:
State: IL

Vax Date: 04/12/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: had vertigo, ran into a wall; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (had vertigo, ran into a wall) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 12-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (had vertigo, ran into a wall). At the time of the report, VERTIGO (had vertigo, ran into a wall) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication not provided. Treatment medication not provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1606542
Sex: F
Age: 71
State: NJ

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: aches; needed rest; Tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (aches), BED REST (needed rest) and FATIGUE (Tired) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced PAIN (aches), BED REST (needed rest) and FATIGUE (Tired). At the time of the report, PAIN (aches), BED REST (needed rest) and FATIGUE (Tired) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication not provided. Treatment medication not provided. This case was linked to MOD-2021-073946 (E2B Linked Report).; Sender's Comments: MOD-2021-073946:Second dose

Other Meds:

Current Illness:

ID: 1606543
Sex: M
Age:
State: MO

Vax Date:
Onset Date: 04/11/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: now he need to wait 2 weeks before getting his 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (now he need to wait 2 weeks before getting his 2nd dose) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (now he need to wait 2 weeks before getting his 2nd dose). On 11-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (now he need to wait 2 weeks before getting his 2nd dose) had resolved. Not Provided Concomitant medication not provided. Treatment medication not provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1606544
Sex: F
Age: 47
State: CA

Vax Date: 03/13/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: inadvertently administered with 1.0 ml of the vaccine; inadvertently administered with 1.0 ml of the vaccine; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Apr-2021 and was forwarded to Moderna on 12-Apr-2021. This spontaneous case was reported by a health care professional and describes the occurrence of ACCIDENTAL OVERDOSE (inadvertently administered with 1.0 ml of the vaccine) and INCORRECT DOSE ADMINISTERED (inadvertently administered with 1.0 ml of the vaccine) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 016B21A,) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form(s). On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL OVERDOSE (inadvertently administered with 1.0 ml of the vaccine) and INCORRECT DOSE ADMINISTERED (inadvertently administered with 1.0 ml of the vaccine). At the time of the report, ACCIDENTAL OVERDOSE (inadvertently administered with 1.0 ml of the vaccine) and INCORRECT DOSE ADMINISTERED (inadvertently administered with 1.0 ml of the vaccine) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1606545
Sex: F
Age:
State:

Vax Date: 04/01/2021
Onset Date: 04/02/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Nausea; Swollen arms; Itchiness; Dizzy; Tenderness; Redness; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arms), PRURITUS (Itchiness), DIZZINESS (Dizzy), TENDERNESS (Tenderness) and ERYTHEMA (Redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event (No medical history reported). On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced TENDERNESS (Tenderness), ERYTHEMA (Redness) and VACCINATION SITE PAIN (Pain at injection site). On 11-Apr-2021, the patient experienced PERIPHERAL SWELLING (Swollen arms), PRURITUS (Itchiness) and DIZZINESS (Dizzy). On 12-Apr-2021, the patient experienced NAUSEA (Nausea). On 03-Apr-2021, TENDERNESS (Tenderness) and VACCINATION SITE PAIN (Pain at injection site) had resolved. At the time of the report, PERIPHERAL SWELLING (Swollen arms), PRURITUS (Itchiness), DIZZINESS (Dizzy), ERYTHEMA (Redness) and NAUSEA (Nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information was included prednisone 20 mg for five days and Mupirosin 2% ointment three times a day. Company Comment: Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1606546
Sex: F
Age:
State: NC

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: sore arm; tiredness; Felt warm; not feeling well; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), FEELING HOT (Felt warm), MALAISE (not feeling well), CHILLS (Chills) and FATIGUE (tiredness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced FEELING HOT (Felt warm), MALAISE (not feeling well) and CHILLS (Chills). On 06-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (tiredness). At the time of the report, PAIN IN EXTREMITY (sore arm), FEELING HOT (Felt warm), MALAISE (not feeling well), CHILLS (Chills) and FATIGUE (tiredness) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication reported. Treatment information not provided. Most recent FOLLOW-UP information incorporated above includes: On 12-Apr-2021: New events were added chills,feeling not well and felling warm

Other Meds:

Current Illness:

ID: 1606547
Sex: F
Age: 71
State: KS

Vax Date: 02/18/2021
Onset Date: 03/04/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. No Medical History information was reported. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced DIARRHOEA (diarrhea). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE]) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (diarrhea) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication not provided. This case was linked to US-MODERNATX, INC.-MOD-2021-073992 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-073992:

Other Meds:

Current Illness:

ID: 1606548
Sex: F
Age:
State: NJ

Vax Date: 02/08/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness). At the time of the report, DIZZINESS (Dizziness) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. "Upon internal review on 04-Aug-21, the age units was corrected 66 years."

Other Meds:

Current Illness:

ID: 1606549
Sex: M
Age: 71
State: CA

Vax Date: 03/17/2021
Onset Date: 03/24/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. No Medical history has been reported. Concomitant products included FLUVOXAMINE MALEATE (LUVOX), LAMOTRIGINE (LAMICTAL), OLANZAPINE (ZYPREXA), ATORVASTATIN, MELATONIN, NEBIVOLOL HYDROCHLORIDE (BYSTOLIC), LANSOPRAZOLE (PREVACID), TESTOSTERONE, FINASTERIDE (PROSCAR), TAMSULOSIN HYDROCHLORIDE (FLOMAX RELIEF), WARFARIN and TRAZODONE for an unknown indication. On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced DIARRHOEA (diarrhea). At the time of the report, DIARRHOEA (diarrhea) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Weight decreased: decreased (Low) Decreased. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment medication were not provided.

Other Meds: LUVOX; LAMICTAL; ZYPREXA; ATORVASTATIN; MELATONIN; BYSTOLIC; PREVACID; TESTOSTERONE; PROSCAR; FLOMAX RELIEF; WARFARIN; TRAZODONE

Current Illness:

ID: 1606550
Sex: F
Age: 71
State: KS

Vax Date: 02/18/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 022M20A) for COVID-19 vaccination. No Medical History information was reported. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, DIARRHOEA (diarrhea) outcome was unknown. Not Provided Concomitant medication not provided. Treatment medication included immodium. Action taken with mRNA-1273 in response to the events was not Applicable. This case was linked to US-MODERNATX, INC.-MOD-2021-073987 (E2B Linked Report). This case was linked to MOD-2021-073987 (Patient Link).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-073987:

Other Meds:

Current Illness:

ID: 1606551
Sex: F
Age: 27
State: IN

Vax Date: 04/02/2021
Onset Date: 04/02/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Injection site warm to touch; Injection site pain; Injection site swelling; Fatigue; Chills; Headache; Muscle pain; Joint pain; Nausea; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE WARMTH, VACCINATION SITE PAIN, VACCINATION SITE SWELLING, FATIGUE, and CHILLS in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE WARMTH, VACCINATION SITE PAIN, VACCINATION SITE SWELLING, FATIGUE, CHILLS, HEADACHE, MYALGIA, ARTHRALGIA, and NAUSEA. At the time of the report, VACCINATION SITE WARMTH, VACCINATION SITE PAIN, VACCINATION SITE SWELLING, FATIGUE, CHILLS, HEADACHE, MYALGIA, ARTHRALGIA, and NAUSEA outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 130/84 (High). On an unknown date, Body temperature: 97.9 (normal). On an unknown date, Heart rate: 82 (normal). On an unknown date, Respiratory rate: 16 (normal). The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication was reported. No treatment medication was reported. Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Reporter details updated, patient demography updated, first dose details updated, event details were updated, lab data detail updated. On 16-Jul-2021: Email correspondence received and it contains No New Information.

Other Meds:

Current Illness:

ID: 1606552
Sex: F
Age: 63
State: TN

Vax Date: 04/08/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: rashes on the arm; rashes turned to blisters that dried up; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rashes on the arm) and BLISTER (rashes turned to blisters that dried up) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 08-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (rashes on the arm) and BLISTER (rashes turned to blisters that dried up). At the time of the report, RASH (rashes on the arm) and BLISTER (rashes turned to blisters that dried up) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant product use was reported No treatment information was provided

Other Meds:

Current Illness:

ID: 1606553
Sex: M
Age: 63
State: FL

Vax Date: 03/19/2021
Onset Date: 03/26/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: If scratched the rash area becomes red; If scratched the rash area becomes irritated; Itching right forearm; Rash on his right forearm; Itching left forearm; Rash on his left forearm (injected Arm); This spontaneous case was reported by a consumer and describes the occurrence of SKIN IRRITATION (If scratched the rash area becomes irritated), PRURITUS (Itching right forearm), ERYTHEMA (If scratched the rash area becomes red), RASH (Rash on his right forearm) and VACCINATION SITE PRURITUS (Itching left forearm) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching left forearm) and VACCINATION SITE RASH (Rash on his left forearm (injected Arm)). On 02-Apr-2021, the patient experienced PRURITUS (Itching right forearm) and RASH (Rash on his right forearm). On 12-Apr-2021, the patient experienced SKIN IRRITATION (If scratched the rash area becomes irritated) and ERYTHEMA (If scratched the rash area becomes red). At the time of the report, SKIN IRRITATION (If scratched the rash area becomes irritated), PRURITUS (Itching right forearm), ERYTHEMA (If scratched the rash area becomes red), RASH (Rash on his right forearm), VACCINATION SITE PRURITUS (Itching left forearm) and VACCINATION SITE RASH (Rash on his left forearm (injected Arm)) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1606554
Sex: M
Age: 58
State: KS

Vax Date: 03/16/2021
Onset Date: 03/19/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (tightness in the chest), COUGH (coughed up some phlegm) and NECK PAIN (soreness in both sides of the neck) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. Concurrent medical conditions included Hypertension and Heavy smoker. On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced CHEST DISCOMFORT (tightness in the chest), COUGH (coughed up some phlegm) and NECK PAIN (soreness in both sides of the neck). At the time of the report, CHEST DISCOMFORT (tightness in the chest) and COUGH (coughed up some phlegm) had resolved and NECK PAIN (soreness in both sides of the neck) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications include Blood pressure medication. Treatment medication included Acetaminophen. Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: F/U received on 14-may-2021,Updated event outcome of neck pain from recovered to not recovered.

Other Meds:

Current Illness: Heavy smoker; Hypertension

ID: 1606555
Sex: F
Age: 52
State: TX

Vax Date: 02/26/2021
Onset Date: 04/08/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Antibodies IGG test negative 2 weeks after second dose; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Apr-2021. The most recent information was received on 01-Jul-2021 and was forwarded to Moderna on 01-Jul-2021. This spontaneous case was reported by a patient family member or friend and describes the occurrence of SARS-COV-2 ANTIBODY TEST NEGATIVE (Antibodies IGG test negative 2 weeks after second dose) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 030M20A) for COVID-19 vaccination. Concurrent medical conditions included Glioblastoma. Concomitant products included APIXABAN (ELICUIS) from 15-Sep-2020 to an unknown date for an unknown indication. On 26-Feb-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021 at 11:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SARS-COV-2 ANTIBODY TEST NEGATIVE (Antibodies IGG test negative 2 weeks after second dose). At the time of the report, SARS-COV-2 ANTIBODY TEST NEGATIVE (Antibodies IGG test negative 2 weeks after second dose) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, SARS-CoV-2 antibody test: negative (Negative) IgG: Negative. Treatment information was not provided by the reporter Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Significant Follow-up: Patient demographics updated, Concomitant product added

Other Meds: ELICUIS

Current Illness: Glioblastoma

ID: 1606556
Sex: F
Age: 57
State: CO

Vax Date: 03/16/2021
Onset Date: 04/12/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: UTI; may have a bladder infection as she has some symptoms; This spontaneous case was reported by a consumer and describes the occurrence of CYSTITIS (may have a bladder infection as she has some symptoms) and URINARY TRACT INFECTION (UTI) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced CYSTITIS (may have a bladder infection as she has some symptoms). On an unknown date, the patient experienced URINARY TRACT INFECTION (UTI). The patient was treated with AZITHROMYCIN (AZO) for Adverse event, at an unspecified dose and frequency. At the time of the report, CYSTITIS (may have a bladder infection as she has some symptoms) and URINARY TRACT INFECTION (UTI) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were provided. Most recent FOLLOW-UP information incorporated above includes: On 31-Jul-2021: Follow-up information received on 31-Jul-2021 and included Event UTI added with outcome. Treatment medication also added that was not included from original source document.

Other Meds:

Current Illness:

ID: 1606557
Sex: F
Age:
State: FL

Vax Date: 02/23/2021
Onset Date: 02/23/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: She has already passed 6 weeks from first dose/ could not receive 2nd Moderna dose; Next day the glands became huge and swollen/still has swollen glands on the left side; Headache; Glands started hurting; Stiff neck; Malaise; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiff neck), MALAISE (malaise), PRODUCT DOSE OMISSION ISSUE (She has already passed 6 weeks from first dose/ could not receive 2nd Moderna dose), LYMPHADENOPATHY (Glands started hurting) and LYMPHADENOPATHY (Next day the glands became huge and swollen/still has swollen glands on the left side) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Blood pressure high since 2005, Hypogammaglobulinemia since 2000, Hypercholesteraemia since 2005, Immune disorder (NOS), Sleep disorder, Migraine, Seafood allergy (crab), Drug allergy (Tegretrol) and Penicillin allergy. Concomitant products included LISINOPRIL and METOPROLOL for Blood pressure management, IMMUNOGLOBULIN HUMAN NORMAL (GAMUNEX C) for Hypogammaglobulinemia, TOPIRAMATE for Migraine, QUETIAPINE for Sleep disorder. On 23-Feb-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiff neck). 23-Feb-2021, the patient experienced MALAISE (malaise), LYMPHADENOPATHY (Glands started hurting) and HEADACHE (Headache). On 24-Feb-2021, the patient experienced LYMPHADENOPATHY (Next day the glands became huge and swollen/still has swollen glands on the left side). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (She has already passed 6 weeks from first dose/ could not receive 2nd Moderna dose). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiff neck), MALAISE (malaise), LYMPHADENOPATHY (Glands started hurting) and HEADACHE (Headache) outcome was unknown, PRODUCT DOSE OMISSION ISSUE (She has already passed 6 weeks from first dose/ could not receive 2nd Moderna dose) had resolved and LYMPHADENOPATHY (Next day the glands became huge and swollen/still has swollen glands on the left side) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Antibody test: 0 (abnormal) Antibodies spike protein test done, came back showing 0 antibodies.. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. On 27 Jul 2021 patient mentioned that she still didn't received her second dose. Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Follow received on 18MAY2021 contains patient's demographics and additional medical history details. Vaccine administration time added, Concomitant medication details, event start date and additional event malaise added. Treatment medication added. On 27-Jul-2021: Follow-up received, lab data added, event out come for still has swollen glands on left side updated to not recovered.

Other Meds: LISINOPRIL; GAMUNEX C; METOPROLOL; QUETIAPINE; TOPIRAMATE

Current Illness: Blood pressure high; Drug allergy (Tegretrol); Hypercholesteraemia; Hypogammaglobulinemia; Immune disorder (NOS); Migraine; Penicillin allergy; Seafood allergy (crab); Sleep disorder

ID: 1606558
Sex: M
Age: 77
State:

Vax Date: 03/25/2021
Onset Date: 04/02/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash at injection site) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. No Medical History information was reported. On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE RASH (Rash at injection site). At the time of the report, VACCINATION SITE RASH (Rash at injection site) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1606559
Sex: F
Age:
State: IN

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: hands started shaking; lightheaded; This spontaneous case was reported by a nurse and describes the occurrence of TREMOR (hands started shaking) and DIZZINESS (lightheaded) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039k20A) for COVID-19 vaccination. No Medical History information was reported. On 06-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 06-Apr-2021, the patient experienced TREMOR (hands started shaking) and DIZZINESS (lightheaded). DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Apr-2021, Blood pressure measurement: 118/72. On 06-Apr-2021, Heart rate: 06-apr-2021. On 06-Apr-2021, Oxygen saturation: 06-apr-2021. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1606560
Sex: F
Age: 50
State: CO

Vax Date: 04/02/2021
Onset Date: 04/10/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: it puffed out; it was really swollen; redness has spread down to her elbow; there's like a hardness to it; fever; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of SKIN SWELLING (it puffed out), SWELLING (it was really swollen), ERYTHEMA (redness has spread down to her elbow), INDURATION (there's like a hardness to it) and PYREXIA (fever) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication. On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced SKIN SWELLING (it puffed out), SWELLING (it was really swollen), ERYTHEMA (redness has spread down to her elbow), INDURATION (there's like a hardness to it), PYREXIA (fever) and FATIGUE (tiredness). At the time of the report, SKIN SWELLING (it puffed out), SWELLING (it was really swollen), ERYTHEMA (redness has spread down to her elbow), INDURATION (there's like a hardness to it), PYREXIA (fever) and FATIGUE (tiredness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported.

Other Meds: TYLENOL

Current Illness:

ID: 1606561
Sex: F
Age:
State: OH

Vax Date: 01/08/2021
Onset Date: 02/17/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Inappropriate age at vaccine administration; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 012L20A) for COVID-19 vaccination. No medical history was provided by the reporter. On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration). On 17-Feb-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. Treatment information was not provided. This case was linked to MOD-2021-013640 (Patient Link).

Other Meds:

Current Illness:

ID: 1606562
Sex: F
Age: 78
State: MO

Vax Date: 03/10/2021
Onset Date: 04/08/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: itch 2 days ago which was only once in a while but was more like a faint itch; the area from the injection site turned into a pink color which was rather large (at least 3-4inches and 2inches wide) like a rash.; injection site turned really red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (injection site turned really red), VACCINATION SITE PRURITUS (itch 2 days ago which was only once in a while but was more like a faint itch) and VACCINATION SITE RASH (the area from the injection site turned into a pink color which was rather large (at least 3-4inches and 2inches wide) like a rash.) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 027L20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included HYDRALAZINE for Blood pressure, SIMVASTATIN for Cholesterol, HYDROCODONE BITARTRATE, PARACETAMOL (NORCO) for Pain, AMITRIPTYLINE and BROMAZEPAM for an unknown indication. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site turned really red). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itch 2 days ago which was only once in a while but was more like a faint itch) and VACCINATION SITE RASH (the area from the injection site turned into a pink color which was rather large (at least 3-4inches and 2inches wide) like a rash.). At the time of the report, VACCINATION SITE ERYTHEMA (injection site turned really red), VACCINATION SITE PRURITUS (itch 2 days ago which was only once in a while but was more like a faint itch) and VACCINATION SITE RASH (the area from the injection site turned into a pink color which was rather large (at least 3-4inches and 2inches wide) like a rash.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications reported. No treatment reported

Other Meds: Amitriptyline; Bromazepam; Hydralazine; Norco; Simvastatin

Current Illness:

ID: 1606563
Sex: F
Age: 66
State: FL

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: diarrhea; heartburn; tired, worn out; fever for 3-4 days; 100 F; left arm is red and swollen from elbow to neck; painful arm, couldn't lift; itchy arm; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHEA (diarrhea), PERIPHERAL SWELLING (left arm is red and swollen from elbow to neck), PAIN IN EXTREMITY (painful arm, couldn't lift), PRURITUS (itchy arm) and DYSPEPSIA (heartburn) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced PERIPHERAL SWELLING (left arm is red and swollen from elbow to neck) and PAIN IN EXTREMITY (painful arm, couldn't lift). 07-Apr-2021, the patient experienced PRURITUS (itchy arm). On an unknown date, the patient experienced DIARRHEA (diarrhea), DYSPEPSIA (heartburn), FATIGUE (tired, worn out) and PYREXIA (fever for 3-4 days; 100 F). The patient was treated with CLINDAMYCIN at an unspecified dose and frequency. At the time of the report, DIARRHEA (diarrhea), PERIPHERAL SWELLING (left arm is red and swollen from elbow to neck), PAIN IN EXTREMITY (painful arm, couldn't lift), DYSPEPSIA (heartburn), FATIGUE (tired, worn out) and PYREXIA (fever for 3-4 days; 100 F) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information not provided. List of concomitant medication were not given.

Other Meds:

Current Illness:

ID: 1606564
Sex: M
Age:
State: NJ

Vax Date:
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Tested positive for covid-19; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for covid-19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for covid-19). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for covid-19) outcome was unknown. Unknown The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications or treatment information was provided.

Other Meds:

Current Illness:

ID: 1606565
Sex: M
Age:
State: SC

Vax Date: 03/12/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Can't raise his hand for a day or 2; Coughing; Sinus strain; Sick for 18 hours; Sore arm; Aching all over; Head hurt bad; Fever for 101 degree; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Can't raise his hand for a day or 2), COUGH (Coughing), SINUS DISORDER (Sinus strain), ILLNESS (Sick for 18 hours) and PAIN IN EXTREMITY (Sore arm) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 in 2020. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (Can't raise his hand for a day or 2), COUGH (Coughing), SINUS DISORDER (Sinus strain), ILLNESS (Sick for 18 hours), PAIN IN EXTREMITY (Sore arm), MYALGIA (Aching all over), HEADACHE (Head hurt bad), PYREXIA (Fever for 101 degree) and FATIGUE (Fatigue). At the time of the report, MOBILITY DECREASED (Can't raise his hand for a day or 2), COUGH (Coughing), SINUS DISORDER (Sinus strain), ILLNESS (Sick for 18 hours), PAIN IN EXTREMITY (Sore arm), MYALGIA (Aching all over), HEADACHE (Head hurt bad), PYREXIA (Fever for 101 degree) and FATIGUE (Fatigue) was resolving. Not Provided mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. Concurrent medication not provided. Treatment medication not provided. This case was linked to MOD-2021-074036 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 12-Apr-2021: Follow-up information received on 14-MAY-2021 contains significant information: The outcome of the events changed from unknown to resolving.

Other Meds:

Current Illness:

ID: 1606566
Sex: U
Age:
State: TN

Vax Date:
Onset Date: 04/11/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Patient received the dose beyond the recommended expiration date; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received the dose beyond the recommended expiration date) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received the dose beyond the recommended expiration date). On 11-Apr-2021, EXPIRED PRODUCT ADMINISTERED (Patient received the dose beyond the recommended expiration date) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1606567
Sex: F
Age: 69
State: AZ

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Lethargic; Injection site was very inflamed; Itchy; Sore; injection site hot; injection site redness/ and the size of small ball; Rock hard (injection site); This spontaneous case was reported by a consumer and describes the occurrence of LIPOHYPERTROPHY (Rock hard (injection site)), LETHARGY (Lethargic), INJECTION SITE INFLAMMATION (Injection site was very inflamed), PRURITUS (Itchy) and MYALGIA (Sore) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Co-suspect product included non-company product IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (DUONEB) for an unknown indication. The patient's past medical history included No adverse event (No relevant medical history provided. ). Concomitant products included MULTIVITAMINS;MINERALS for an unknown indication. On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (DUONEB) (unknown route) at an unspecified dose. On 08-Apr-2021, the patient experienced LIPOHYPERTROPHY (Rock hard (injection site)), INJECTION SITE INFLAMMATION (Injection site was very inflamed), PRURITUS (Itchy), INJECTION SITE WARMTH (injection site hot) and INJECTION SITE ERYTHEMA (injection site redness/ and the size of small ball). On 09-Apr-2021, the patient experienced LETHARGY (Lethargic). On an unknown date, the patient experienced MYALGIA (Sore). At the time of the report, LIPOHYPERTROPHY (Rock hard (injection site)), LETHARGY (Lethargic), INJECTION SITE INFLAMMATION (Injection site was very inflamed), PRURITUS (Itchy), INJECTION SITE WARMTH (injection site hot) and INJECTION SITE ERYTHEMA (injection site redness/ and the size of small ball) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds: MULTIVITAMINS;MINERALS

Current Illness:

ID: 1606568
Sex: F
Age: 61
State: CA

Vax Date: 04/10/2021
Onset Date: 04/11/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Couldn't open her eyes; Whole face and lips are swollen; Whole face and lips are swollen; Red, itchy, "kind of burning" rash on the left side of face and neck; Right thumb is numb; Red, itchy, "kind of burning" rash on the left side of face and neck; Really tired; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Couldn't open her eyes), SWELLING FACE (Whole face and lips are swollen), LIP SWELLING (Whole face and lips are swollen), PRURITUS (Red, itchy, "kind of burning" rash on the left side of face and neck) and HYPOAESTHESIA (Right thumb is numb) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Asthma. Concomitant products included SALBUTAMOL (VENTOLIN [SALBUTAMOL]) for Asthma. On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced SOMNOLENCE (Couldn't open her eyes), SWELLING FACE (Whole face and lips are swollen), LIP SWELLING (Whole face and lips are swollen), PRURITUS (Red, itchy, "kind of burning" rash on the left side of face and neck), HYPOAESTHESIA (Right thumb is numb), ERYTHEMA (Red, itchy, "kind of burning" rash on the left side of face and neck) and FATIGUE (Really tired). At the time of the report, SOMNOLENCE (Couldn't open her eyes), SWELLING FACE (Whole face and lips are swollen), LIP SWELLING (Whole face and lips are swollen), PRURITUS (Red, itchy, "kind of burning" rash on the left side of face and neck), HYPOAESTHESIA (Right thumb is numb), ERYTHEMA (Red, itchy, "kind of burning" rash on the left side of face and neck) and FATIGUE (Really tired) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Apr-2021, Body temperature: 100 (High) Temperature of 100F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication including "Another inhaler" for asthma was reported. Treatment using was reported.

Other Meds: VENTOLIN [SALBUTAMOL]

Current Illness: Asthma

ID: 1606569
Sex: M
Age:
State: CA

Vax Date: 01/25/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Missed the window for the second dose; Tested positive; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed the window for the second dose) and SARS-COV-2 TEST POSITIVE (Tested positive) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. No Medical History information was reported. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed the window for the second dose) and SARS-COV-2 TEST POSITIVE (Tested positive). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed the window for the second dose) had resolved and SARS-COV-2 TEST POSITIVE (Tested positive) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment medication was reported. No concomitant medication was reported.

Other Meds:

Current Illness:

ID: 1606570
Sex: M
Age:
State: SC

Vax Date: 03/12/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Ache all over; Sinus drain two nights in row; Sore throat; Could not walk had to kneel down to open the fridge.; Feeling so bad; Did not feel like sitting up or lying down; Sore arm" but less painful than the first time; Sick like a dog; Fever; Head hurt real bad; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Ache all over), RHINORRHOEA (Sinus drain two nights in row), OROPHARYNGEAL PAIN (Sore throat), GAIT DISTURBANCE (Could not walk had to kneel down to open the fridge.) and FEELING ABNORMAL (Feeling so bad) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 in 2020. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Ache all over), RHINORRHOEA (Sinus drain two nights in row), OROPHARYNGEAL PAIN (Sore throat), GAIT DISTURBANCE (Could not walk had to kneel down to open the fridge.), FEELING ABNORMAL (Feeling so bad), FEELING ABNORMAL (Did not feel like sitting up or lying down), PAIN IN EXTREMITY (Sore arm" but less painful than the first time), ILLNESS (Sick like a dog), PYREXIA (Fever ) and HEADACHE (Head hurt real bad). At the time of the report, PAIN (Ache all over), RHINORRHOEA (Sinus drain two nights in row), OROPHARYNGEAL PAIN (Sore throat), GAIT DISTURBANCE (Could not walk had to kneel down to open the fridge.), FEELING ABNORMAL (Feeling so bad), FEELING ABNORMAL (Did not feel like sitting up or lying down), PAIN IN EXTREMITY (Sore arm" but less painful than the first time), ILLNESS (Sick like a dog), PYREXIA (Fever ) and HEADACHE (Head hurt real bad) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: 38.7 (High) 101.7 degree Fahrenheit. Concurrent medication not provided. Treatment medication not provided This case was linked to MOD-2021-074025 (Patient Link).

Other Meds:

Current Illness:

ID: 1606571
Sex: F
Age: 51
State: NY

Vax Date: 03/16/2021
Onset Date: 03/18/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo (room spinning when she tries to get up from bed).) and PALPITATIONS (occasional palpitations) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The patient's past medical history included No adverse event (Medical history was not provided). On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) UNK DF. On 18-Mar-2021, the patient experienced VERTIGO (Vertigo (room spinning when she tries to get up from bed).) and PALPITATIONS (occasional palpitations). At the time of the report, VERTIGO (Vertigo (room spinning when she tries to get up from bed).) had not resolved and PALPITATIONS (occasional palpitations) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.

Other Meds:

Current Illness:

ID: 1606572
Sex: F
Age: 31
State: GA

Vax Date: 04/10/2021
Onset Date: 04/10/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very very sick), HEADACHE (extreme headache), PAIN IN EXTREMITY (both arms very very sore), NAUSEA (nausea, eating makes it worse) and VOMITING (vomiting a few times) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042BDIA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication. On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced ILLNESS (very very sick), HEADACHE (extreme headache), PAIN IN EXTREMITY (both arms very very sore), NAUSEA (nausea, eating makes it worse), VOMITING (vomiting a few times), ABDOMINAL PAIN (abdominal cramps), DIARRHOEA (diarrhea), CONSTIPATION (constipation, unsure if it is from TUMS) and FEELING ABNORMAL (feels lousy and can't take it anymore). At the time of the report, ILLNESS (very very sick), HEADACHE (extreme headache), PAIN IN EXTREMITY (both arms very very sore), NAUSEA (nausea, eating makes it worse), VOMITING (vomiting a few times), ABDOMINAL PAIN (abdominal cramps), DIARRHOEA (diarrhea), CONSTIPATION (constipation, unsure if it is from TUMS) and FEELING ABNORMAL (feels lousy and can't take it anymore) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Treatment to the events given as Tylenol. This case was linked to MOD-2021-117955.

Other Meds: TYLENOL

Current Illness:

ID: 1606573
Sex: F
Age: 63
State: TN

Vax Date: 03/09/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: itches; arm swollen; Red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itches), VACCINATION SITE SWELLING (arm swollen) and VACCINATION SITE ERYTHEMA (Red) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itches), VACCINATION SITE SWELLING (arm swollen) and VACCINATION SITE ERYTHEMA (Red). At the time of the report, VACCINATION SITE PRURITUS (itches), VACCINATION SITE SWELLING (arm swollen) and VACCINATION SITE ERYTHEMA (Red) outcome was unknown. Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications information was reported. No treatment medications were provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1606574
Sex: M
Age:
State: NY

Vax Date: 02/12/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: blood glucose high; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (blood glucose high) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 02A621A and 030M20A.) for COVID-19 vaccination. No medical history was reported by the reporter. Concomitant products included LINAGLIPTIN (TRADJENTA), INSULIN DETEMIR (LEVEMIR), CHLORTHALIDONE, CLOPIDOGREL BISULFATE (PLAVIX) and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BLOOD GLUCOSE INCREASED (blood glucose high). At the time of the report, BLOOD GLUCOSE INCREASED (blood glucose high) had resolved. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Dec-2020, Glycosylated haemoglobin: 6.5 (High) High. On 08-Apr-2021, Glycosylated haemoglobin: 8.2 (High) High. Patient had a readjustment in insulin pump settings and Issues lasted around 6 weeks after vaccination was noted. This case was linked to MOD-2021-276362 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow-up received on 4-Aug-2021 contains significant information. Event outcome changed to recovered/resolved

Other Meds: TRADJENTA; LEVEMIR; CHLORTHALIDONE; PLAVIX; ASPIRIN 81

Current Illness:

ID: 1606575
Sex: M
Age: 53
State: LA

Vax Date: 03/22/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Diarrhea; Fatigue; Thrown up, described as vomited; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), FATIGUE (Fatigue), VOMITING (Thrown up, described as vomited) and NAUSEA (Nausea) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. Concomitant products included AMLODIPINE, LOSARTAN and TEMAZEPAM for an unknown indication. On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea), FATIGUE (Fatigue), VOMITING (Thrown up, described as vomited) and NAUSEA (Nausea). On 12-Apr-2021, DIARRHOEA (Diarrhea) had resolved. At the time of the report, FATIGUE (Fatigue), VOMITING (Thrown up, described as vomited) and NAUSEA (Nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. He called his primary care physician about three or four days ago and was told that he does not know anything about the vaccine and there was nothing which he could tell the patient about the vaccine. The patient asks whether it is common for the reported symptoms to be lasting this long and asks is it safe for him to get the second dose, scheduled for next Monday 19Apr2021, with these ongoing symptoms.The patient grants permission for Safety follow up and grants permission for Safety to follow up with his health care professional. Treatment details include, the patient has not treated his symptoms

Other Meds: AMLODIPINE; LOSARTAN; TEMAZEPAM

Current Illness:

ID: 1606576
Sex: F
Age: 74
State: GA

Vax Date: 03/19/2021
Onset Date: 03/20/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Discoloration like a bruise at the injection site; Raised rash on arm (red itchy lump)/Raised rash at injection site; Injection site redness; Injection site itchiness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Discoloration like a bruise at the injection site), VACCINATION SITE RASH (Raised rash on arm (red itchy lump)/Raised rash at injection site), INJECTION SITE ERYTHEMA (Injection site redness) and INJECTION SITE PRURITUS (Injection site itchiness) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. Concurrent medical conditions included Seasonal allergy, High cholesterol and Anxiety. Concomitant products included SERTRALINE HCL for Anxiety, PRAVASTATIN for Cholesterol, VITAMIN D [VITAMIN D NOS], VITAMIN D3, DOCOSAHEXAENOIC ACID, EICOSAPENTAENOIC ACID, TOCOPHEROL (OMEGA 3 [DOCOSAHEXAENOIC ACID;EICOSAPENTAENOIC ACID;TOCOPHEROL]) and ASCORBIC ACID (ESTER C [ASCORBIC ACID]) for an unknown indication. On 19-Mar-2021 at 11:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced VACCINATION SITE RASH (Raised rash on arm (red itchy lump)/Raised rash at injection site), INJECTION SITE ERYTHEMA (Injection site redness) and INJECTION SITE PRURITUS (Injection site itchiness). On 20-Apr-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE DISCOLOURATION (Discoloration like a bruise at the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and CORTISONE at an unspecified dose and frequency. On 09-Apr-2021, VACCINATION SITE RASH (Raised rash on arm (red itchy lump)/Raised rash at injection site), INJECTION SITE ERYTHEMA (Injection site redness) and INJECTION SITE PRURITUS (Injection site itchiness) had resolved. On 23-Apr-2021, VACCINATION SITE DISCOLOURATION (Discoloration like a bruise at the injection site) had resolved with sequelae. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. This case was linked to MOD-2021-080431 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Added information of second dose and new event Discoloration like a bruise at the injection site. On 23-Apr-2021: Reporter's phone number and email address, concomitant drugs , 2nd dose lot number and stop date of Discoloration like a bruise at the injection site event. On 18-May-2021: Patient's demographic details, Patient's medical history, concomitant medication details, and outcome of events, Causality were updated.

Other Meds: PRAVASTATIN; VITAMIN D [VITAMIN D NOS]; SERTRALINE HCL; VITAMIN D3; OMEGA 3 [DOCOSAHEXAENOIC ACID;EICOSAPENTAENOIC ACID;TOCOPHEROL]; ESTER C [ASCORBIC ACID]

Current Illness: Anxiety; High cholesterol; Seasonal allergy

ID: 1606577
Sex: F
Age: 64
State: VA

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Her arm is sore and swollen and a little hot; Her arm is sore and swollen and a little hot; Her arm is sore and swollen and a little hot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Her arm is sore and swollen and a little hot), VACCINATION SITE PAIN (Her arm is sore and swollen and a little hot) and VACCINATION SITE SWELLING (Her arm is sore and swollen and a little hot) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025821A) for COVID-19 vaccination. No Medical History information was reported. On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Her arm is sore and swollen and a little hot), VACCINATION SITE PAIN (Her arm is sore and swollen and a little hot) and VACCINATION SITE SWELLING (Her arm is sore and swollen and a little hot). At the time of the report, VACCINATION SITE WARMTH (Her arm is sore and swollen and a little hot), VACCINATION SITE PAIN (Her arm is sore and swollen and a little hot) and VACCINATION SITE SWELLING (Her arm is sore and swollen and a little hot) had not resolved. Action taken with mRNA-1273 in response to the event was not applicable. No concomitant medication was reported. Treatment medication was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1606578
Sex: M
Age: 41
State: CA

Vax Date: 08/20/2021
Onset Date: 08/20/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: not known

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Pt was supposed to receive 2nd dose of pfizer covid-19 vaccine. However, pt received moderna covid-19.

Other Meds: Not known

Current Illness:

ID: 1606579
Sex: F
Age: 25
State: AR

Vax Date: 07/31/2021
Onset Date: 08/01/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: No

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Lack of muscle control in the hand arm and shoulder Loss of sensation in the hand arm and shoulder Paralysis in the hand arm or shoulder Sharp stabbing pain in shoulder. Numbness and tingling. Overall muscle weakness. Limited range of motions and movements.

Other Meds: N/a

Current Illness: N/a

ID: 1606580
Sex: F
Age: 46
State: CA

Vax Date: 05/22/2021
Onset Date: 07/01/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: No

Symptom List: Pain in extremity

Symptoms: Worsening heel and ankle pain (limiting ability to stand and walk), bladder not emptying properly with pain and pressure, eyes are burning all day & night, vision blurry. Doctor mentioned reactive arthritis to vaccine as a possibility since I?m HLA B27 positive.

Other Meds: Spironolactone 25 mg/day, oral iron, multivitamin, fish oil, vitamin D, zinc, magnesium

Current Illness: None

ID: 1606581
Sex: F
Age: 44
State: PA

Vax Date: 08/16/2021
Onset Date: 08/16/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: NSAIDS, shellfish,treenut, eggs, flu vaccine, sulfa medicine

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Shortness of breath, chest tightening onset approximately and hr to an 1hr and 15 mins after Pfizer vaccine administered. Oral steroidal treatment prescribed Place on prednisone 50mg once a day for a total of 10 days

Other Meds: Albuterol inhaler, losartan potassium, zyrtec, tylenol

Current Illness: None

ID: 1606582
Sex: F
Age: 36
State:

Vax Date: 03/12/2021
Onset Date: 04/09/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: weakness; trembling; fireworks in her brain,; profusing sweating; dry mouth; headache; chills; fever of a 104.1,; nausea; severe body aches; extreme pain going down to the wrist, the armpit and pectoral muscle.; extreme pain going down to the wrist, the armpit and pectoral muscle.; extreme pain going down to the wrist, the armpit and pectoral muscle; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (extreme pain going down to the wrist, the armpit and pectoral muscle.), AXILLARY PAIN (extreme pain going down to the wrist, the armpit and pectoral muscle.), TREMOR (trembling), HEAD DISCOMFORT (fireworks in her brain,) and HYPERHIDROSIS (profusing sweating) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041B21A and 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event (No Reported Medical History) on 12-Apr-2021. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021 at 8:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced MYALGIA (extreme pain going down to the wrist, the armpit and pectoral muscle). On 09-Apr-2021 at 11:00 AM, the patient experienced PAIN IN EXTREMITY (extreme pain going down to the wrist, the armpit and pectoral muscle.) and AXILLARY PAIN (extreme pain going down to the wrist, the armpit and pectoral muscle.). On 09-Apr-2021 at 2:00 PM, the patient experienced PAIN (severe body aches). On 09-Apr-2021 at 7:00 PM, the patient experienced TREMOR (trembling), HEAD DISCOMFORT (fireworks in her brain,), HYPERHIDROSIS (profusing sweating), DRY MOUTH (dry mouth), HEADACHE (headache), CHILLS (chills), PYREXIA (fever of a 104.1,) and NAUSEA (nausea). On an unknown date, the patient experienced ASTHENIA (weakness). At the time of the report, PAIN IN EXTREMITY (extreme pain going down to the wrist, the armpit and pectoral muscle.), AXILLARY PAIN (extreme pain going down to the wrist, the armpit and pectoral muscle.), TREMOR (trembling), HEAD DISCOMFORT (fireworks in her brain,), HYPERHIDROSIS (profusing sweating), DRY MOUTH (dry mouth), PAIN (severe body aches), CHILLS (chills), PYREXIA (fever of a 104.1,) and MYALGIA (extreme pain going down to the wrist, the armpit and pectoral muscle) outcome was unknown and ASTHENIA (weakness), HEADACHE (headache) and NAUSEA (nausea) had not resolved. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Apr-2021, Body temperature: 104.1 104.1. There are no concomitant medications reported. The treatments listed were aspirin and children's acetaminophen. Company Comment: Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1606583
Sex: F
Age:
State: MD

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: fever; chills; fatigue; nausea; headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), PYREXIA (fever), CHILLS (chills), FATIGUE (fatigue) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced HEADACHE (headache). On 10-Apr-2021, the patient experienced PYREXIA (fever), CHILLS (chills), FATIGUE (fatigue) and NAUSEA (nausea). At the time of the report, HEADACHE (headache), PYREXIA (fever), CHILLS (chills), FATIGUE (fatigue) and NAUSEA (nausea) was resolving. No concomitant medication reported. No treatment was provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1606584
Sex: F
Age: 61
State: PA

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of inappropriate schedule of product administration (received Moderna vaccine while positive with COVID-19) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 007B21A) for COVID-19 immunization. No medical history reported. On Mar 30, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 30, 2021, patient experienced inappropriate schedule of product administration (received Moderna vaccine while positive with COVID-19). On Mar 30, 2021, inappropriate schedule of product administration (received Moderna vaccine while positive with COVID-19) resolved. Diagnostic results: On Mar 27, 2021, SARS-CoV-2 test: Positive. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information reported.

Other Meds:

Current Illness:

ID: 1606585
Sex: M
Age:
State: PA

Vax Date: 03/23/2021
Onset Date: 04/01/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Diagnosed with Covid-19; Dehydrated; unable to lift his left arm for 2 to 4 days; oxygen at 92; vomitting; fever at 102.9 degrees Fahrenheit; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed with Covid-19), DEHYDRATION (Dehydrated), MOBILITY DECREASED (unable to lift his left arm for 2 to 4 days), OXYGEN SATURATION DECREASED (oxygen at 92) and VOMITING (vomitting) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), GLYBURIDE, METFORMIN and LISINOPRIL for an unknown indication. On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced DEHYDRATION (Dehydrated), MOBILITY DECREASED (unable to lift his left arm for 2 to 4 days), OXYGEN SATURATION DECREASED (oxygen at 92), VOMITING (vomitting), PYREXIA (fever at 102.9 degrees Fahrenheit) and FATIGUE (Fatigue). On 05-Apr-2021, the patient experienced COVID-19 (Diagnosed with Covid-19). At the time of the report, COVID-19 (Diagnosed with Covid-19), DEHYDRATION (Dehydrated), MOBILITY DECREASED (unable to lift his left arm for 2 to 4 days), OXYGEN SATURATION DECREASED (oxygen at 92), VOMITING (vomitting), PYREXIA (fever at 102.9 degrees Fahrenheit) and FATIGUE (Fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment medication was reported. No concomitant medication was reported. This case was linked to US-MODERNATX, INC.-MOD-2021-073823 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-073823:Crossed linked

Other Meds: ASPIRIN (E.C.); GLYBURIDE; METFORMIN; LISINOPRIL

Current Illness:

ID: 1606586
Sex: F
Age: 67
State: NY

Vax Date: 03/11/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Two doses of vaccine at interval of 4 days; This spontaneous case was reported by a physician and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Two doses of vaccine at interval of 4 days) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. No Medical History information was reported. On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Two doses of vaccine at interval of 4 days). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Two doses of vaccine at interval of 4 days) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. As reported patients has been accidently given 2 doses at interval of 4 days. No concomitant medications were reported. Treatment information was not reported.

Other Meds:

Current Illness:

ID: 1606587
Sex: F
Age: 53
State: PA

Vax Date: 04/10/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: arm was killing her; has bleed so much from the shot; when she wipped the site, there were blood clots on her napkin; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was killing her), VACCINATION SITE HAEMORRHAGE (has bleed so much from the shot) and VACCINATION COMPLICATION (when she wipped the site, there were blood clots on her napkin) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm was killing her), VACCINATION SITE HAEMORRHAGE (has bleed so much from the shot) and VACCINATION COMPLICATION (when she wipped the site, there were blood clots on her napkin). At the time of the report, PAIN IN EXTREMITY (arm was killing her), VACCINATION SITE HAEMORRHAGE (has bleed so much from the shot) and VACCINATION COMPLICATION (when she wipped the site, there were blood clots on her napkin) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication were not reported. Treatment details were not provided.

Other Meds:

Current Illness:

ID: 1606588
Sex: F
Age:
State: MI

Vax Date: 03/18/2021
Onset Date: 03/22/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: terrible leg pains every night, legs are throbbing; she can't sleep, she can't nap; legs are achy; legs feel fatigued; extreme pain in her right foot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (extreme pain in her right foot), PAIN IN EXTREMITY (terrible leg pains every night, legs are throbbing), INSOMNIA (she can't sleep, she can't nap), PAIN IN EXTREMITY (legs are achy) and MUSCLE FATIGUE (legs feel fatigued) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 38A21A) for COVID-19 vaccination. No Medical History information was reported. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PAIN IN EXTREMITY (extreme pain in her right foot). On an unknown date, the patient experienced PAIN IN EXTREMITY (terrible leg pains every night, legs are throbbing), INSOMNIA (she can't sleep, she can't nap), PAIN IN EXTREMITY (legs are achy) and MUSCLE FATIGUE (legs feel fatigued). At the time of the report, PAIN IN EXTREMITY (extreme pain in her right foot), PAIN IN EXTREMITY (terrible leg pains every night, legs are throbbing), INSOMNIA (she can't sleep, she can't nap), PAIN IN EXTREMITY (legs are achy) and MUSCLE FATIGUE (legs feel fatigued) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment medication was not provided

Other Meds:

Current Illness:

ID: 1606589
Sex: F
Age:
State: NE

Vax Date: 03/23/2021
Onset Date: 03/24/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: nauseous; neck/base of neck; numbness; pain; deep ache; broken collar bone; golf ball; swelling; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (golf ball), BONE PAIN (broken collar bone), MUSCULOSKELETAL STIFFNESS (neck/base of neck), HYPOAESTHESIA (numbness) and PAIN (pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 23-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced PERIPHERAL SWELLING (golf ball) and VACCINATION SITE SWELLING (swelling). On 25-Mar-2021, the patient experienced BONE PAIN (broken collar bone). On 26-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (neck/base of neck), HYPOAESTHESIA (numbness), PAIN (pain) and PAIN (deep ache). On 10-Apr-2021, the patient experienced NAUSEA (nauseous). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency; ACETAMINOPHEN at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 11-Apr-2021, NAUSEA (nauseous) had resolved. At the time of the report, PERIPHERAL SWELLING (golf ball), BONE PAIN (broken collar bone), MUSCULOSKELETAL STIFFNESS (neck/base of neck), HYPOAESTHESIA (numbness), PAIN (pain), PAIN (deep ache) and VACCINATION SITE SWELLING (swelling) outcome was unknown. No concomitant medications were provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable, reporter didn't provide any causality assessment. Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Non significant follow up.AE Contact information updated.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 26 October 2021 2:21am